10 new clinical trials for TNBC, HER2 positive, and other subtypes of stage IV breast cancer (stage 4) have been added to BreastCancerTrials.org (BCT) in the last month. These clinical trials can also be found on Metastatic Trial Search (MTS).
Stage IV All Subtypes
- Immunotherapy CDX-527 for Advanced Breast Cancer
- SGN-B6A in Advanced Breast Cancer
- Gene Therapy Ad-p53 In Combination With Immunotherapy for Advanced Breast Cancer
- ONCR-177 Alone or With Pembrolizumab in Advanced Breast Cancer
Stage IV Triple Negative Breast Cancer (TNBC)
- Immunotherapy TAK-573 for Advanced Triple Negative Breast Cancer
- Immunotherapy TBio-6517 Alone or With Pembrolizumab for Advanced Triple Negative Breast Cancer
- BCA101 for Metastatic Triple Negative Breast Cancer That Tests Positive for EGFR
Stage IV HR Positive (HR+) Breast Cancer
Stage IV HER2 Positive Breast Cancer
- Alpelisib for Advanced HER2+ Breast Cancer with a PIK3CA Mutation
- Immunotherapy ACE1702 for Advanced HER2 Expressing (HER2 IHC 2+ or 3+) Breast Cancer
Last Modified on August 17, 2020
